Di Stefano, Danilo Alessio http://orcid.org/0000-0002-7991-9946
Vinci, Raffaele
Capparè, Paolo
Gherlone, Enrico Felice
Article History
Received: 11 January 2021
Accepted: 30 March 2021
First Online: 11 June 2021
Declarations
:
: The local ethical committee approved the study.
: Not applicable.
: Danilo Alessio Di Stefano has a consultancy relationship with Bioteck S.p.A., which donated the equine xenografts used in this study. Data belonged to the authors, and none of the manufacturers cited in the study interfered with its execution or results.